Inpharma Weekly

, Volume 1038, Issue 1, pp 3–4 | Cite as

State of play of research into dementias

  • David B Jack
Newsletter Article


A conference organised by the Lancet was dedicated to examining recent progress in dementia research. Entitled ‘ The Challenge of the Dementias ’ [ Edinburgh, Scotland; April 1996 ], the conference brought together experts in epidemiology, genetics, neuroimaging and drug treatment, to discuss today’s issues. Their conclusions indicate that the greatest progress of recent years has been in the genetic field, with the discovery of the apolipoprotein E type 4 allele (APOE-ε4) and its link to an increased risk of late-onset Alzheimer’s disease. A number of epidemiological findings have also been made, and diagnostic methods have benefited from several advances. However, apart from the development of tacrine and second-generation cholinesterase inhibitors, such as galantamine, there has been little progress in the drug treatment of this condition.


Dementia Aspirin Tacrine Galantamine Senile Dementia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1996

Authors and Affiliations

  • David B Jack

There are no affiliations available

Personalised recommendations